← Back
Data updated: Mar 10, 2026
PERRIGO ISRAEL
Pharmaceuticals
PERRIGO ISRAEL is a pharmaceutical company with 2 FDA-approved products.
2013
Since
2
Drugs
-
Trials
13
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
TESTOSTERONE 2025-12-17
Labeling
TESTOSTERONE 2025-07-15
Labeling
TESTOSTERONE 2025-07-15
Labeling
TESTOSTERONE 2025-07-11
Labeling
TESTOSTERONE 2025-07-11
Labeling
TESTOSTERONE 2025-07-11
Labeling
TESTOSTERONE 2025-07-11
Labeling
TESTOSTERONE 2025-07-11
Labeling
TESTOSTERONE 2025-07-11
Labeling
TESTOSTERONE 2025-07-11
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (0)
Discontinued (1)
Company Info
- First Approval
- 2013-01-31
- Latest
- 2016-10-25
- Applications
- 2